Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 676 to 700 of 2422

TitleReference numberPublishedLast updated
Acumen IQ sensor for predicting hypotension riskMIB266
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillationTA249
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillationTA256
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA355
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA275
Atrial fibrillation: diagnosis and managementNG196
Plus Sutures for preventing surgical site infectionMTG59
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitisTA708
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA709
Ravulizumab for treating atypical haemolytic uraemic syndromeTA710
Laser lithotripsy for difficult-to-treat bile duct stonesIPG699
Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valveIPG700
Patient experience in adult NHS services: improving the experience of care for people using adult NHS servicesCG138
Shared decision makingNG197
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancerTA707
SYNE-COV for predicting COVID-19 outcomesMIB264
Autism spectrum disorder in adults: diagnosis and managementCG142
Autism spectrum disorder in under 19s: support and managementCG170
Ozanimod for treating relapsing–remitting multiple sclerosisTA706
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705
WoundExpress to manage lower leg woundsMIB261
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Electrohydraulic lithotripsy for difficult-to-treat bile duct stonesIPG698

Results per page

  1. 10
  2. 25
  3. 50
  4. All